× Industry Reports Services Press Release Contact us About us

Africa Molecular Diagnostics Market Size By Technology (PCR, In-situ Hybridization, Chips and Microassays, Mass Spectrometry, Sequencing, Isothermal Application), By Application (Infectious Disease, {Flu, RSV Virus, Tuberculosis, Meningitis, HIV, Hepatitis C, Hepatitis B, HPV, STD, [Chlamydia, Gonorrhea], Dengue, H. Pylori, TORCH}, Blood Screening, Genetic Testing, Oncology Testing), Industry Analysis Report, Country Outlook (Uganda, Kenya, Malawi, Tanzania, Nigeria, Ethiopia, Zimbabwe, Mozambique, Rwanda, South Africa, Cameroon, DRC), Application Potential, Competitive Market Share & Forecast, 2020 - 2026

Published Date: September 2020 | Publisher: Graphical Research Report ID: GR1413 | Delivery : PDF

Report Content

Chapter 1.     Methodology

1.1.           Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters        

1.2.           Data sources       

1.3.                     References & sources

1.3.1.  Secondary

1.3.2.  Primary

Chapter 2.     Executive Summary

2.1.           Africa molecular diagnostics industry summary, 2015 - 2026

2.1.1.  Country trends

2.1.2.  Application trends

2.1.3.  Technology trends

Chapter 3.     Industry Insights

3.1.           Industry segmentation

3.2.                     Industry outlook, 2015 - 2026

3.3.                     Major factor analysis

3.3.1.  Drivers

3.3.1.1.   Growing disease burden in African region

3.3.1.2.   Incremental innovations and advancements in molecular diagnostics techniques

3.3.1.3.   Rising elderly population fuels the market growth

3.3.1.4.   Increasing initiatives by the government and industry players

3.3.2.  Restraints & challenges

3.3.2.1.  High cost of disease diagnostics and limited accessibility

3.3.2.2.  Lack of trained professionals in Africa

3.4.           COVID-19 impact analysis

3.5.                     Porter’s analysis

3.6.                     Competitive review, 2019

3.7.                     PEST analysis

Chapter 4.         Africa Molecular Diagnostics Market Share, By Application

4.1.           Key trends in Africa molecular diagnostics, by type

4.2.                     Infectious disease

4.2.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.2.  Flu

4.2.2.1.   Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.3.  RSV virus

4.2.3.1.   Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.4.  Tuberculosis

4.2.4.1.   Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.5.  Meningitis

4.2.5.1.   Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.6.  HIV

4.2.6.1.   Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.7.  Hepatitis C

4.2.7.1.   Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.8.  Hepatitis B

4.2.8.1.   Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.9.  HPV

4.2.9.1.   Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.10.  STD

4.2.10.1.    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.10.2.    Chlamydia

4.2.10.2.1.    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.10.3.    Gonorrhea

4.2.10.3.1.    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.10.4.    Others

4.2.10.4.1.    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.11.  Dengue

4.2.11.1.    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.12.  H.Pylori

4.2.12.1.    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.13.  TORCH

4.2.13.1.    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.2.14.  Others

4.2.14.1.    Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.3.           Blood screening

4.3.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.4.           Genetic testing

4.4.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.5.           Oncology testing

4.5.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)      

Chapter 5.           Africa Molecular Diagnostics Market Size, By Technology

5.1.           Key trends in Africa molecular diagnostics, by technology

5.2.                     PCR

5.2.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.3.           In-situ hybridization

5.3.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.4.           Chips and Microarrays

5.4.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.5.        Mass spectrometry

5.5.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.6.       Sequencing

5.6.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.7.        Isothermal amplification

5.7.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.8.   Others

5.8.1.  Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 6.         Africa Molecular Diagnostics Market Growth, By Country

6.1.           Key trends in Africa molecular diagnostics, by country

6.2.                     Uganda

6.2.1.  Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.2.1.1.   Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.2.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.2.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.3.           Kenya

6.3.1.  Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.3.1.1.   Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.3.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.3.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.4.           Malawi

6.4.1.  Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.4.1.1.   Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.4.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.4.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.5.           Tanzania

6.5.1.  Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.5.1.1.   Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.5.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.5.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.6.           Nigeria

6.6.1.  Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.6.1.1.   Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.6.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.6.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.7.           Ethiopia

6.7.1.  Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.7.1.1.   Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.7.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.7.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.8.           Zimbabwe

6.8.1.  Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.8.1.1.   Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.8.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.8.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.9.           Mozambique

6.9.1.  Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.9.1.1.   Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.9.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.9.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.10.        Rwanda

6.10.1. Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.10.1.1. Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.10.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.10.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.11.        South Africa

6.11.1. Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.11.1.1. Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.11.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.11.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.12.        Cameroon

6.12.1. Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.12.1.1. Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.12.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.12.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

6.13.        DRC

6.13.1. Market estimates and forecast, by application, 2015 - 2026 (USD Million)

6.13.1.1. Market estimates and forecast, by infectious disease, 2015 - 2026 (USD Million)

6.13.1.1.1.    Market estimates and forecast, by STDs, 2015 - 2026 (USD Million)

6.13.2.  Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

Chapter 7.         Company Profiles

7.1.           Abbott Laboratories

7.1.1.  Business overview

7.1.2.  Financial data

7.1.3.  Product landscape

7.1.4.  Strategic outlook

7.2.           Agilent Technologies, Inc. (Dako)

7.2.1.  Business overview

7.2.2.  Financial data

7.2.3.  Product landscape

7.2.4.  Strategic outlook

7.3.           Analytik Jena AG (Endress+Hauser AG)

7.3.1.  Business overview

7.3.2.  Financial data

7.3.3.  Product landscape

7.3.4.  Strategic outlook

7.4.           Becton, Dickinson and Company

7.4.1.  Business overview

7.4.2.  Financial data

7.4.3.  Product landscape

7.4.4.  Strategic outlook

7.5.           BioMérieux SA

7.5.1.  Business overview

7.5.2.  Financial data

7.5.3.  Product landscape

7.5.4.  Strategic outlook

7.6.           Bio-Rad Laboratories

7.6.1.  Business overview

7.6.2.  Financial data

7.6.3.  Product landscape

7.6.4.  Strategic outlook

7.7.           Bio-Techne

7.7.1.  Business overview

7.7.2.  Financial data

7.7.3.  Product landscape

7.7.4.  Strategic outlook

7.8.           Celtic Molecular Diagnostics

7.8.1.   Business overview

7.8.2.   Financial data

7.8.3.   Product landscape

7.8.4.   Strategic outlook

7.9.           Cleaver Scientific Ltd

7.9.1.   Business overview

7.9.2.   Financial data

7.9.3.   Product landscape

7.9.4.   Strategic outlook

7.10.        Danaher Corporation

7.10.1. Business overview

7.10.2. Financial data

7.10.3. Product landscape

7.10.4. Strategic outlook

7.11.        F. Hoffmann-La Roche Ltd

7.11.1. Business overview

7.11.2. Financial data

7.11.3. Product landscape

7.11.4. Strategic outlook

7.12.        Hologic Inc. (Gen Probe)  

7.12.1. Business overview

7.12.2. Financial data

7.12.3. Product landscape

7.12.4. Strategic outlook

7.13.        Johnson & Johnson Services, Inc. 

7.13.1. Business overview

7.13.2. Financial data

7.13.3. Product landscape

7.13.4.  Strategic outlook

7.14.        Myriad Genetics, Inc.  

7.14.1. Business overview

7.14.2. Financial data

7.14.3. Product landscape

7.14.4.  Strategic outlook

7.15.        Qiagen  

7.15.1. Business overview

7.15.2. Financial data

7.15.3. Product landscape

7.15.4.  Strategic outlook

7.16.        Siemens Healthcare GmbH  

7.16.1. Business overview

7.16.2. Financial data

7.16.3. Product landscape

7.16.4.  Strategic outlook

7.17.        Sysmex Corporation  

7.17.1. Business overview

7.17.2. Financial data

7.17.3. Product landscape

7.17.4.  Strategic outlook

7.18.        Thermo Fisher Scientific  

7.18.1. Business overview

7.18.2. Financial data

7.18.3. Product landscape

7.18.4.  Strategic outlook


Select License

Africa Molecular Diagnostics Market Research 2026 | Trends & Growth


Related Reports
Why Choose us?
  • On-Time Delivery
  • Assured Quality
  • Industry Experts
  • Payment Security
Share Social-media